• Biome executes trading terms with Green Cross Health New Zealand, the country's premier integrated healthcare provider
• Green Cross Health operates New Zealand's largest pharmacy network with 328 stores processing 40% of national prescription volume
• Activated Probiotics to commence retail launch into Life Pharmacy and UniChem pharmacies from September 2025

Biome Australia Limited (ASX: BIO) has announced the execution of trading terms with Green Cross Health Limited (NZX: GXH), positioning Activated Probiotics for retail launch across New Zealand's largest pharmacy network from September 2025. This partnership represents a significant milestone in Biome's international expansion strategy, providing immediate access to 328 established pharmacies operating under the Life Pharmacy and UniChem brands. Green Cross Health processes over 34 million prescriptions annually, representing 40% of New Zealand's total prescription volume, while serving 1.95 million loyalty program members across the country. The partnership leverages Biome's existing wholesale distribution relationship with Propharma (EBOS), creating a comprehensive supply chain solution. Green Cross Health's dual-brand retail strategy provides optimal market coverage across different consumer segments, with Life Pharmacy focusing on urban professionals and UniChem emphasizing community pharmacy services. The partnership addresses New Zealand's favorable regulatory environment for probiotics, allowing Biome to leverage its clinical trial data for product positioning and professional recommendations. This expansion directly advances Biome's Vision 27 strategic framework, which targets at least $75 million in cumulative revenue over FY25-FY27. Activated Probiotics represents one of Australia's highest growth practitioner-only and probiotics brands, supported by randomized, double-blind, placebo-controlled trials for various health applications. The partnership positions Biome to capitalize on New Zealand's dynamic pharmacy market, where traditional operators are emphasizing professional differentiation and clinical services.

Biome expects this relationship to generate meaningful revenue contribution as the company establishes market presence and leverages Green Cross Health's extensive consumer touchpoints and clinical credibility.

The partnership with Green Cross Health represents a significant strategic milestone in Biome's international expansion program, providing an ideal platform for introducing Activated Probiotics to New Zealand consumers and healthcare professionals.